Integer (NYSE:ITGR) will be issuing its quarterly earnings data before the market opens on Thursday, November 1st. Analysts expect the company to announce earnings of $0.92 per share for the quarter. Integer has set its FY18 guidance at $3.35-3.65 EPS.
Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, August 2nd. The medical equipment provider reported $1.06 EPS for the quarter, topping analysts’ consensus estimates of $0.88 by $0.18. Integer had a net margin of 6.63% and a return on equity of 12.60%. The firm had revenue of $313.00 million during the quarter, compared to analyst estimates of $379.41 million. During the same quarter last year, the business posted $0.62 EPS. The company’s revenue was up 11.4% on a year-over-year basis. On average, analysts expect Integer to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Integer stock opened at $74.18 on Wednesday. Integer has a 52 week low of $42.50 and a 52 week high of $84.20. The company has a debt-to-equity ratio of 1.64, a current ratio of 3.80 and a quick ratio of 2.95. The company has a market capitalization of $2.31 billion, a P/E ratio of 26.40 and a beta of 0.84.
ITGR has been the subject of a number of recent analyst reports. Royal Bank of Canada reaffirmed a “hold” rating and issued a $72.00 price objective on shares of Integer in a research note on Friday, August 3rd. Zacks Investment Research lowered shares of Integer from a “buy” rating to a “hold” rating in a research note on Wednesday, September 12th. Northcoast Research raised shares of Integer from a “neutral” rating to a “buy” rating in a research note on Friday, July 13th. KeyCorp reaffirmed an “overweight” rating and issued a $78.00 price objective (up previously from $65.00) on shares of Integer in a research note on Friday, July 6th. They noted that the move was a valuation call. Finally, TheStreet raised shares of Integer from a “c+” rating to a “b” rating in a research note on Monday, August 6th. Three equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Integer presently has a consensus rating of “Buy” and an average price target of $76.80.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates through two segments, Medical and Non-Medical. The company offers arthroscopic devices and components, such as shaver blades and burrs, ablation probes, and suture anchors; laparoscopic and general surgery products, including trocars, endoscopes and laparoscopes, closure devices, harmonic scalpels, bipolar energy delivery devices, radio frequency probes, thermal tumor ablation devices, and ophthalmic surgery devices; and biopsy and drug delivery products.
Read More: Cost of Debt
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.